Levelling the SPC playing field

“The EU’s highest court, in a 2013 ruling, held it is possible for a product to be classified as a medical device in one EU member state and a medicine in another.”

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Regulation & Industry

What makes a life sciences deal stack up for buyers?

25 August 2026 While promising science draws in buyers, intellectual property determines the price, terms, and viability of an agreement. LSIPR digs into what buyers are looking for—and the biggest turn-offs that destroy a deal.

Regulation & Industry

UK appoints ex-engineer as new intellectual property Minister

24 August 2026 Labour MP for Stockton North takes up a new role as Minister for Science, Innovation and Investment within Andy Burnham’s government.

Careers

Stris & Maher opens new Dallas office with partner hires

24 August 2026 The four-person team adds significant life sciences experience to the litigation boutique, drawn to move firms by Stris’ “outstanding trial lawyers” and “sophisticated appellate capabilities”.

More features

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

The UPC plugs another gap in its procedural rulebook

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

UPC upholds injunction in Invisalign maker’s software dispute with rival

EU court under pressure to define SPC limits in patent row

Court narrows Mylan’s Copaxone suit but key claims survive

Patent office fee increases: What applicants must know

IndiaMart v CDSCO: A test of intermediary liability

Levelling the SPC playing field

More on this story

Editor's picks

Editor's picks

More features